Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Mar;96(9):e5904.
doi: 10.1097/MD.0000000000005904.

Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities

Pegah Golabi  1 , Sofie Fazel, Munkhzul Otgonsuren, Mehmet Sayiner, Cameron T Locklear, Zobair M Younossi
Affiliations
Observational Study

Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities

Pegah Golabi et al. Medicine (Baltimore). 2017 Mar.

Abstract

Hepatocellular carcinoma (HCC) is among the most common types of cancer. Liver transplantation (LT) and surgical resection (SR) are primary surgical treatment options for HCC.The aim of the study was to assess mortality within 2 years postdiagnosis among patients with HCC according to their treatment modalities.We examined data from the Surveillance, Epidemiology and End Results (SEER)-Medicare database between 2001 and 2009. SEER registries collect demographics, cancer stage and historical types, and treatments. Medicare claims include diagnoses, procedures, and survival status for each beneficiary. Patients with HCC were identified using the International Classification of Disease Oncology, Third Edition Site code C22.0 and Histology Code 8170-8175. Treatment modalities were LT, SR, or nonsurgical treatment.Total of 11,187 cases was included (age at diagnosis: 72 years, 69% male, 67% White). HCC patients who underwent LT were younger (61 vs 71 years), sicker (presence of decompensated cirrhosis: 80% vs 23%), and less likely to die within 2 years (29% vs 44%, all P < 0.01), compared to SR patients. In multivariate analysis, older age (HR: 1.01 [95% CI = 1.01-1.01]), stage of HCC other than local (HR: 1.81[95%CI = 1.70-1.91]), and being treated with SR (HR: 1.95 [95%CI = 1.55-2.46]) were independent predictors of mortality within 2 years. Furthermore, the presence of decompensated cirrhosis (HR: 1.84 [95%CI = 1.73-1.96]) and alcoholic liver disease (HR: 1.19[95%CI = 1.11-1.28]) increased within 2 years mortality.Mortality within 2 years postdiagnosis of HCC was significantly higher in patients treated with SR than LT.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Kaplan–Meier survival curves for HCC patients by liver transplant and primary site surgery status in the subcohort. HCC = hepatocellular carcinoma.
Figure 2
Figure 2
Kaplan–Meier survival curves for HCC patients by liver transplant and primary site surgery status in the main cohort. HCC = hepatocellular carcinoma.
See this image and copyright information in PMC

References

    1. WHO. World Cancer Report 2014— Available at: http://www.who.int/mediacentre/factsheets/fs297/en. Accessed 2014.
    1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012;379:1245–55. - PubMed
    1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557–76. - PubMed
    1. Stewart BW, Wild CPE. World Cancer Report 2014. 2014;Lyon, France: International Agency for Research on Cancer, http://www.ebrary.com.proxy.library.vcu.edu - PubMed
    1. SEER. SEER Stat Fact Sheets: Liver and Intrahepatic Bile Duct Cancer—2015. Available at: http://seer.cancer.gov/statfacts/html/livibd.html Accessed 2015.

Publication types